Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2006; 12(43): 6941-6948
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6941
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6941
Table 1 Genes of canadidate angiogenesis inhibitors
| Candidate | Reference(s) |
| 16 kD prolactin fragment1 | 3 |
| Angiostatin1 | 3, 36 |
| Arresten1 | 3 |
| Canstatin1 | 3 |
| Endostatin1 | 3 |
| Endothelial-monocyte activating polypeptide-II (EMAP-II)1 | 3 |
| Fragments of hepatocyte growth factor (HGF) | |
| NK4 | 40, 41 |
| HGFK1 | 42 |
| Human rubonuclease inhibitor (hRI) | 20, 21 |
| Interferon-inducible protein-10 (IP-10)1 | 3 |
| Interferons1 | 3 |
| Interleukin-12 (IL-12)1 | 28, 29 |
| Interleukin-18 (IL-18)1 | 3 |
| Interleukin-24 (IL-24) | 37, 38, 39 |
| Maspin | 17, 18, 19 |
| p531 | 3 |
| Pigment epithelium-derived factor (PEDF) | 31, 32, 33, 34 |
| Platelet factor-41 | 3 |
| Restin1 | 3 |
| Soluble FMS-like tyrosine kinase receptor 1 (sFlt-1) | 26, 27 |
| Survivin | 22, 23, 24, 25 |
| Thrombospondin-1 (THBS1)1 | 3 |
| Tissue inhibitors of metalloproteinases (TIMPs)1 | 3, 35 |
| Tumor necrosis factor alpha (TNF-α)1 | 3 |
| Tumstatin1 | 3 |
| Vastatin1 | 43 |
- Citation: Liu CC, Shen Z, Kung HF, Lin MC. Cancer gene therapy targeting angiogenesis: An updated Review. World J Gastroenterol 2006; 12(43): 6941-6948
- URL: https://www.wjgnet.com/1007-9327/full/v12/i43/6941.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i43.6941